Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Intravac appoints Nathalie Laarakker as CFO

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team. …
Appointment

Smithers promotes Nikki Lucas to Principal Project Manager

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nikki Lucas has been appointed Principal Project Manager within Smithers’ Medical Device Physical Testing team. Lucas has over a decade …
Appointment

New CEO appointed at Nordic Nanovector

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector have appointed Peter Braun as their new Chief Executive Officer. Braun is an experienced and entrepreneurial pharmaceutical leader, …
Appointment
chas_taylor

Ceryx Medical announce new chairman Chas Taylor

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cardiovascular technology company Ceryx Medical have appointed Chas Taylor as their new chairman. The appointment comes at an interesting time …
Appointment
moderna_norwood_plant

500,000 Moderna COVID-19 vaccines to arrive in UK next month

March 29, 2021 Sales and Marketing COVID-19, Moderna, Vaccine

More than 500,000 doses of Moderna’s COVID-19 vaccine are set to arrive in the UK next month, ministers have confirmed. …
News
GSK building

GSK & Vir’s COVID-19 treatment shows 85% efficacy in Phase III trial

March 29, 2021 Sales and Marketing COVID-19, GSK, Phase III trial, covid-19 treatment, vir

GSK and Vir Biotechnology have submitted an Emergency Use Authorization request to the FDA for their VIR-7831 therapy for the …
News

Janssen’s multiple sclerosis treatment recommended by EMA

March 29, 2021 Sales and Marketing CHMP, EMA, Janssen, Johnson & Johnson, PONVORY, multiple sclerosis

Janssen’s PONVORY therapy for the treatment of adults with relapsing forms of multiple sclerosis (MS) has been recommended by the …
News

BATM develops molecular diagnostics test for tuberculosis

March 29, 2021 Sales and Marketing TB, testing

BATM have announced that it has developed a new method for the rapid and comprehensive diagnosis of tuberculosis (TB), which …
News

gaitQ awarded NIHR grant for Parkinson’s wearable tech

March 29, 2021 Sales and Marketing Parkinson's, medical technology

The UK’s National Institute for Health Research (NIHR) has awarded a £135,000 grant to gaitQ, a spin-off from the University …
News

eTheRNA awarded €6.9 million TIGER Grant by European Commission

March 22, 2021 Sales and Marketing Cancer, EU

eTheRNA immunotherapies, a clinical-stage company, has been awarded a grant of €6.9 million by the European Commission to develop a …
News
video_library01

Daiichi Sankyo begins trial for mRNA COVID-19 vaccine in Japan

March 22, 2021 Sales and Marketing COVID-19, Vaccine

Daiichi Sankyo, a global pharmaceutical company that provides services in 20 countries worldwide, has announced the first vaccinations as part …
News

FDA approves Kiniksa’s recurrent pericardis treatment ARCALYST

March 22, 2021 Sales and Marketing FDA

The FDA have approved ARCALYST (rilonacept) for the treatment and risk reduction of recurrent pericardis in adults and children over …
News
roche__tree

Roche lung cancer treatment reports promising results in Phase III

March 22, 2021 Sales and Marketing Roche, oncology

Roche’s IMpower010 study, evaluating Tecentriq (atezolizumab) compared with best supportive care, has shown significant improvement in disease-free survival (DFS) in …
News
astrazeneca_sign_sky

AstraZeneca COVID-19 vaccine achieves safety and efficacy results in US

March 22, 2021 Sales and Marketing

Results from the US trial of AstraZeneca’s COVID-19 vaccine (AZD1222) show it is 79% effective at stopping symptomatic COVID-19 disease …
News
A woman being given eye drops

Ocuphire’s pupil dilation treatment shows promising Phase III trial results

March 15, 2021 Sales and Marketing Ocuphire, eye treatment, nyxol

Ocuphire Pharma’s Nyxol treatment for pharmacologically-induced pupil dilation (mydriasis) has met its primary and secondary endpoints in its Phase III …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026